Citation Impact
Citing Papers
Prognostic and Predictive Values of the Immunoscore in Patients with Rectal Cancer
2014
A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis
2018
Tumoral Lymphocytic Infiltration and Expression of the Chemokine CXCL10 in Breast Cancers from the Ontario Familial Breast Cancer Registry
2012
Systemic Delivery of Microencapsulated 3-Bromopyruvate for the Therapy of Pancreatic Cancer
2014 StandoutNobel
A Cell Proliferation Signature Is a Marker of Extremely Poor Outcome in a Subpopulation of Breast Cancer Patients
2005
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
2016 Standout
Cancer–stromal cell interactions mediated by hypoxia-inducible factors promote angiogenesis, lymphangiogenesis, and metastasis
2012 StandoutNobel
Regulation of the breast cancer stem cell phenotype by hypoxia-inducible factors
2015 StandoutNobel
CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer
2012
The CD44+/CD24-phenotype is enriched in basal-like breast tumors
2008
Expression of Hypoxia-inducible factor 1-α and Vascular endothelial growth factor–C in locally advanced breast cancer patients
2011
Gastric cancer
2016 Standout
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
Lapatinib Plus Paclitaxel Versus Paclitaxel Alone in the Second-Line Treatment of HER2-Amplified Advanced Gastric Cancer in Asian Populations: TyTAN—A Randomized, Phase III Study
2014
Forkhead box transcription factor 1 expression in gastric cancer: FOXM1 is a poor prognostic factor and mediates resistance to docetaxel
2013
The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer
2022 StandoutNobel
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits
2009 Standout
Emerging role of NRF2 in chemoresistance by regulating drug-metabolizing enzymes and efflux transporters
2016
Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis
2014
Nrf2-Keap1 signaling in oxidative and reductive stress
2018 Standout
Almost all articles on cancer prognostic markers report statistically significant results
2007
Mechanisms and strategies to overcome chemotherapy resistance in metastatic breast cancer
2008
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Molecular mechanisms of resistance and toxicity associated with platinating agents
2006 Standout
NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches
2018 Standout
CD8+ cytotoxic T cell and FOXP3+ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes
2011
Do Pressures to Publish Increase Scientists' Bias? An Empirical Support from US States Data
2010 Standout
The hypoxic tumor microenvironment: A driving force for breast cancer progression
2015 StandoutNobel
Monoclonal B cell lymphocytosis in hepatitis C virus infected individuals
2010
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer
2011
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
CpG hypomethylation of MDR1 gene in tumor and serum of invasive ductal breast carcinoma patients
2009
Meta-analysis of gene expression profiles related to relapse-free survival in 1,079 breast cancer patients
2008
Tumour-infiltrating lymphocytes in melanoma prognosis and cancer immunotherapy
2016
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Augmented expression of metallothionein and glutathione S-transferase pi as unfavourable prognostic factors in cisplatin-treated ovarian cancer patients
2005
Lymphangiogenesis and lymphatic metastasis in breast cancer
2009
Cancer-related inflammation and treatment effectiveness
2014 Standout
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients
2009 Standout
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis.
2014
TIMER2.0 for analysis of tumor-infiltrating immune cells
2020 Standout
MCM Paradox: Abundance of Eukaryotic Replicative Helicases and Genomic Integrity
2014
Chemotherapy for advanced gastric cancer
2017 Standout
Functional Nanomaterials for Phototherapies of Cancer
2014 Standout
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
2013 StandoutNobel
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Regulation of cell proliferation by hypoxia-inducible factors
2015 StandoutNobel
Works of Rafał Matkowski being referenced
The prognostic role of tumor-infiltrating CD4 and CD8 T lymphocytes in breast cancer.
2009
Relationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significance
2005
MRP2 (ABCC2, cMOAT) expression in nuclear envelope of primary fallopian tube cancer cells is a new unfavorable prognostic factor
2012
Hepatitis C virus infection and locally advanced splenic marginal zone lymphoma
2007
Multivariate analysis of oestrogen receptor alpha, pS2, metallothionein and CD24 expression in invasive breast cancers
2006
Evaluation of prognostic value of VEGF-C and VEGF-D in breast cancer--10 years follow-up analysis.
2007
Predictive value of lymphocytic infiltration and character of invasive margin following total mesorectal excision with sphincter preservation for the high-risk carcinoma of the rectum.
2007
Prognostic value of immunocytochemical estimation of estrogen receptor (ER) and of pS2 estrogen-dependent protein in cells of mammary ductal carcinoma. Analysis of five-year course of the disease.
2001
E-cadherin and fibronectin expressions have no prognostic role in stage II ductal breast cancer.
2005
Mcm-2 protein expression predicts prognosis better than Ki-67 antigen in oral cavity squamocellular carcinoma.
2006
Immunocytochemical evaluation of metallothionein (MT) expression in myoepithelial cells of ductal mammary carcinoma and its relation to survival time: analysis of 7-year course of the disease.
2002
HER-2 Expression in Immunohistochemistry Has No Prognostic Significance in Gastric Cancer Patients
2012
Paucity of tumor-infiltrating lymphocytes is an unfavorable prognosticator and predicts lymph node metastases in cutaneous melanoma patients.
2015
Analysis of estrogen receptor (ER) and estrogen-dependent pS2 protein expression in cells of mammary ductal carcinoma.
2001